REDTALKS : OUR SERIE OF SCIENTIFIC WEBINARS
CALYM Institute is pleased to announce the launch of scientific webinars on research subjects linked to lymphoma.
You are invited to discover, participate and be part of the lymphoma research community.
-
On the 1st Thursday of each month
-
For one hour, starting 6pm CET
-
For free and for everyone
- In English
SEASON 4: WATCH REPLAYS
REDTALKS S4#2: IDH2 MUTATION IN T-CELL LYMPHOMA: NEW MOUSE MODEL TO INVESTIGATE IDH2 MUTATION IMPACT
REDTALKS S4#1: NOVEL INSIGHT INTO THE PATHOGENESIS OF MEDIASTINAL LYMPHOMAS
COMING SOON!
SEASON 3: WATCH REPLAYS
REDTALKS S3#7: MYC-TRANSLOCATED LEUKEMIAS AND LYMPHOMAS: FROM MULTI-OMICS ANALYSES TO PATHOGENETIC CONCEPTS
See you next season!
See you next season!
REDTALKS S3#6: METABOLIC REGULATION OF HEMOPOIETIC MALIGNANCY
REDTALKS S3#5: COMBINING GLOFITAMAB WITH COSTIMULATORY BISPECIFICS
REDTALKS #4 SAISON 3: PATHOGENESIS OF HODGKIN LYMPHOMA
REDTALKS #3 SAISON 3: UNDERSTANDING THE ROLE OF ONCOGENIC DRIVERS IN T-CELL LYMPHOMA
REDTALKS #2 SAISON 3: TARGETING THE COMMON PROGENITOR CELL TO CURE FOLLICULAR LYMPHOMA
REDTALKS #1 SAISON 3: THE SINGLE-CELL PATHOLOGY LANDSCAPE OF DIFFUSE LARGE B CELL LYMPHOMA
SEASON 2: WATCH REPLAYS
REDTALKS S2#6: APPLICATION OF PET SCANNING IN B CELL LYMPHOMA
REDTALKS SEASON2#5: CAR-T CELLS: NEW TARGETS AND POTENTIAL STRATEGIES FOR CANCER PATIENTS
REDTALKS SEASON2#4: COULD POLATUZUMAB DETHRONE USUAL REGIMEN FOR DLBCL PATIENTS?
REDTALKS SEASON2 #3: CIRCULATING TUMOR DNA (CTDNA) AND LYMPHOMA
REDTALKS SEASON2 #2: PDX A POWERFUL TOOL OF NEW DISCOVERIES AND IMPROVED TREATMENTS
REPLAY: REDTALKS SEASON2 #1: A MACRO VIEW OF THE TUMORAL MICROENVIRONMENT
SEASON 1: WATCH REPLAYS
REDTALKS #1 LYMPHOMA SUGARCOATED
REDTALKS#2 : WHY AI HYPE SHOULD NOT MAKE US LOSE COMMON SENSE?
REDTALKS#3 : “GENETICS PROPOSES, EPIGENETICS DISPOSES”. BUT IT’S ALL IN THE GENES…
REDTALKS #4 DRIVING TOWARD PRECISION MEDICINE FOR MANTLE CELL LYMPHOMA
REDTALKS #5: CD19 CAR T CELLS FOR B-CELL NHL AND CLL: LESSONS LEARNT AND NEXT STEPS
REDTALKS #6: UNDERSTANDING T-CELL LYMPHOMA
REDTALKS #7 : FROM 2 CANCER CENTERS TO INDUSTRY: DRIVING PROGRESS IN BLOOD CANCERS
REDTALKS #8 DEDICATED TO OUR MEMBERS
REDTALKS #9 : EPIGENETIC BASES AND THERAPY LYMPHOMA